These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 27687648)
1. [Efficacy of Yunnan Baiyao as an adjuvant treatment for active ulcerative colitis: an open-label randomized controlled study]. Zhao WZ; Diao N; Gu YX; Zhu XT; Li MS Nan Fang Yi Ke Da Xue Xue Bao; 2016 Aug; 36(9):1186-1191. PubMed ID: 27687648 [TBL] [Abstract][Full Text] [Related]
2. Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study. Marteau P; Probert CS; Lindgren S; Gassul M; Tan TG; Dignass A; Befrits R; Midhagen G; Rademaker J; Foldager M Gut; 2005 Jul; 54(7):960-5. PubMed ID: 15951542 [TBL] [Abstract][Full Text] [Related]
3. The efficacy of Yunnan Baiyao on haemostasis and antiulcer: a systematic review and meta-analysis of randomized controlled trials. Yang B; Xu ZQ; Zhang H; Xu FY; Shi XY; Zou Z; Ling CQ; Tang L Int J Clin Exp Med; 2014; 7(3):461-82. PubMed ID: 24753739 [TBL] [Abstract][Full Text] [Related]
4. MMX mesalazine for the induction of remission of mild-to-moderately active ulcerative colitis: efficacy and tolerability in specific patient subpopulations. Lichtenstein GR; Kamm MA; Sandborn WJ; Lyne A; Joseph RE Aliment Pharmacol Ther; 2008 Jun; 27(11):1094-102. PubMed ID: 18363894 [TBL] [Abstract][Full Text] [Related]
5. Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis. Spanish Group for the Study of Crohn's Disease and Ulcerative Colitis (GETECCU). Fernández-Bañares F; Hinojosa J; Sánchez-Lombraña JL; Navarro E; Martínez-Salmerón JF; García-Pugés A; González-Huix F; Riera J; González-Lara V; Domínguez-Abascal F; Giné JJ; Moles J; Gomollón F; Gassull MA Am J Gastroenterol; 1999 Feb; 94(2):427-33. PubMed ID: 10022641 [TBL] [Abstract][Full Text] [Related]
6. Clinical and biological predictors of response to standardised paediatric colitis therapy (PROTECT): a multicentre inception cohort study. Hyams JS; Davis Thomas S; Gotman N; Haberman Y; Karns R; Schirmer M; Mo A; Mack DR; Boyle B; Griffiths AM; LeLeiko NS; Sauer CG; Keljo DJ; Markowitz J; Baker SS; Rosh J; Baldassano RN; Patel A; Pfefferkorn M; Otley A; Heyman M; Noe J; Oliva-Hemker M; Rufo PA; Strople J; Ziring D; Guthery SL; Sudel B; Benkov K; Wali P; Moulton D; Evans J; Kappelman MD; Marquis MA; Sylvester FA; Collins MH; Venkateswaran S; Dubinsky M; Tangpricha V; Spada KL; Saul B; Wang J; Serrano J; Hommel K; Marigorta UM; Gibson G; Xavier RJ; Kugathasan S; Walters T; Denson LA Lancet; 2019 Apr; 393(10182):1708-1720. PubMed ID: 30935734 [TBL] [Abstract][Full Text] [Related]
7. eHealth: individualization of mesalazine treatment through a self-managed web-based solution in mild-to-moderate ulcerative colitis. Pedersen N; Thielsen P; Martinsen L; Bennedsen M; Haaber A; Langholz E; Végh Z; Duricova D; Jess T; Bell S; Burisch J; Munkholm P Inflamm Bowel Dis; 2014 Dec; 20(12):2276-85. PubMed ID: 25248002 [TBL] [Abstract][Full Text] [Related]
8. Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: a multicenter, randomized, double-blind study. Biancone L; Gionchetti P; Blanco Gdel V; Orlando A; Annese V; Papi C; Sostegni R; D'Incà R; Petruzziello C; Casa A; Sica G; Calabrese E; Campieri M; Pallone F Dig Liver Dis; 2007 Apr; 39(4):329-37. PubMed ID: 17347061 [TBL] [Abstract][Full Text] [Related]
9. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine. Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138 [TBL] [Abstract][Full Text] [Related]
10. Mesalazine granules are superior to Eudragit-L-coated mesalazine tablets for induction of remission in distal ulcerative colitis - a pooled analysis. Leifeld L; Pfützer R; Morgenstern J; Gibson PR; Marakhouski Y; Greinwald R; Mueller R; Kruis W Aliment Pharmacol Ther; 2011 Nov; 34(9):1115-22. PubMed ID: 21923715 [TBL] [Abstract][Full Text] [Related]
11. Long-term outcome of ulcerative colitis in patients who achieve clinical remission with a first course of corticosteroids. Garcia-Planella E; Mañosa M; Van Domselaar M; Gordillo J; Zabana Y; Cabré E; López San Román A; Domènech E Dig Liver Dis; 2012 Mar; 44(3):206-10. PubMed ID: 22079262 [TBL] [Abstract][Full Text] [Related]
12. Evolution and predictive factors of relapse in ulcerative colitis patients treated with mesalazine after a first course of corticosteroids. Bello C; Belaiche J; Louis E; Reenaers C J Crohns Colitis; 2011 Jun; 5(3):196-202. PubMed ID: 21575881 [TBL] [Abstract][Full Text] [Related]
13. Comparison of QD and TID oral mesalazine for maintenance of remission in quiescent ulcerative colitis: a double-blind, double-dummy, randomized multicenter study. Watanabe M; Hanai H; Nishino H; Yokoyama T; Terada T; Suzuki Y Inflamm Bowel Dis; 2013 Jul; 19(8):1681-90. PubMed ID: 23624890 [TBL] [Abstract][Full Text] [Related]
14. Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group. Ardizzone S; Doldo P; Ranzi T; Sturniolo GC; Giglio LA; Annese V; D'Arienzo A; Gaia E; Gullini S; Riegler G; Valentini M; Massa P; Del Piano M; Rossini F; Guidetti CS; Pera A; Greinwald R; Bianchi Porro G Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):677-84. PubMed ID: 10730559 [TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis. Sinha A; Nightingale J; West KP; Berlanga-Acosta J; Playford RJ N Engl J Med; 2003 Jul; 349(4):350-7. PubMed ID: 12878742 [TBL] [Abstract][Full Text] [Related]
16. Combined oral and rectal mesalazine for the treatment of mild-to-moderately active ulcerative colitis: rapid symptom resolution and improvements in quality of life. Probert CS; Dignass AU; Lindgren S; Oudkerk Pool M; Marteau P J Crohns Colitis; 2014 Mar; 8(3):200-7. PubMed ID: 24012063 [TBL] [Abstract][Full Text] [Related]
17. Yunnan Baiyao diminishes lipopolysaccharide-induced inflammation in osteoclasts. Ren X; Zhu Y; Xie L; Zhang M; Gao L; He H J Food Biochem; 2020 Jun; 44(6):e13182. PubMed ID: 32189353 [TBL] [Abstract][Full Text] [Related]
18. MMX Multi Matrix System mesalazine for the induction of remission in patients with mild-to-moderate ulcerative colitis: a combined analysis of two randomized, double-blind, placebo-controlled trials. Sandborn WJ; Kamm MA; Lichtenstein GR; Lyne A; Butler T; Joseph RE Aliment Pharmacol Ther; 2007 Jul; 26(2):205-15. PubMed ID: 17593066 [TBL] [Abstract][Full Text] [Related]
19. 3g mesalazine granules are superior to 9mg budesonide for achieving remission in active ulcerative colitis: a double-blind, double-dummy, randomised trial. Gross V; Bunganic I; Belousova EA; Mikhailova TL; Kupcinskas L; Kiudelis G; Tulassay Z; Gabalec L; Dorofeyev AE; Derova J; Dilger K; Greinwald R; Mueller R; J Crohns Colitis; 2011 Apr; 5(2):129-38. PubMed ID: 21453882 [TBL] [Abstract][Full Text] [Related]
20. Safety and activity of dersalazine sodium in patients with mild-to-moderate active colitis: double-blind randomized proof of concept study. Pontes C; Vives R; Torres F; Panés J Inflamm Bowel Dis; 2014 Nov; 20(11):2004-12. PubMed ID: 25192498 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]